FDA Approves Botox for Lower-Limb Spasticity in Children FDA Approves Botox for Lower-Limb Spasticity in Children

The FDA has approved Botox to ease lower-limb spasticity in children and adolescents aged 2 to 17 years, excluding spasticity caused by cerebral palsy.FDA Approvals

Source: Medscape Neurology and Neurosurgery Headlines - October 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news